Servers and developers
HOME > PAST ISSUE > COVER STORY [Premium content]September 2007
China is carving out a niche in the pharma outsourcing market while local developers still wait for lift off
With America caught up in a credit crunch causing the subprime lending crisis, August didn’t seem a particularly good month to list on the New York Stock Exchange. No one told this to Wuxi Pharmatech, a Shanghai-based pharmaceuticals and biotechnology firm.
Having raised US$185 million through its initial public offering, Wuxi then saw its share price open 30%, up on a day when Wall Street plunged.
Industry watchers believe the strong reception for China’s ...
Having raised US$185 million through its initial public offering, Wuxi then saw its share price open 30%, up on a day when Wall Street plunged.
Industry watchers believe the strong reception for China’s ...
log in to continue reading...
 |
To receive the best China business news that the market has to offer,
subscribe to the China Economic Review.
subscribe to the China Economic Review.